Archive for the ‘Lyme’ Category

How Does the Lyme Spirochete Control OspC?

https://journals.asm.org/doi/10.1128/jb.00440-22

ABSTRACT

The OspC outer-surface lipoprotein is essential for the Lyme disease spirochete’s initial phase of vertebrate infection. Bacteria within the midguts of unfed ticks do not express OspC but produce high levels when ticks begin to ingest blood. Lyme disease spirochetes cease production of OspC within 1 to 2 weeks of vertebrate infection, and bacteria that fail to downregulate OspC are cleared by host antibodies. Thus, tight regulation of OspC levels is critical for survival of Lyme borreliae and, therefore, an attractive target for development of novel treatment strategies. Previous studies determined that a DNA region 5′ of the ospC promoter, the ospC operator, is required for control of OspC production. Hypothesizing that the ospC operator may bind a regulatory factor, DNA affinity pulldown was performed and identified binding by the Gac protein. Gac is encoded by the C-terminal domain of the gyrA open reading frame from an internal promoter, ribosome-binding site, and initiation codon. Our analyses determined that Gac exhibits a greater affinity for ospC operator and promoter DNAs than for other tested borrelial sequences. In vitro and in vivo analyses demonstrated that Gac is a transcriptional repressor of ospC. These results constitute a substantial advance to our understanding of the mechanisms by which the Lyme disease spirochete controls production of OspC.
IMPORTANCE
Borrelia burgdorferi sensu lato requires its surface-exposed OspC protein in order to establish infection in humans and other vertebrate hosts. Bacteria that either do not produce OspC during transmission or fail to repress OspC after infection is established are rapidly cleared by the host. Herein, we identified a borrelial protein, Gac, that exhibits preferential affinity to the ospC promoter and 5′ adjacent DNA. A combination of biochemical analyses and investigations of genetically manipulated bacteria demonstrated that Gac is a transcriptional repressor of ospC. This is a substantial advance toward understanding how the Lyme disease spirochete controls production of the essential OspC virulence factor and identifies a novel target for preventative and curative therapies.

Study: Lyme Forms May Affect Persistence

https://www.mdpi.com/1422-0067/24/6/5594

Pleomorphic Variants of Borreliella (syn. Borrelia) burgdorferi Express Evolutionary Distinct Transcriptomes

1Laboratory of Evolutionary Genetics, Division of Molecular Biology, Ruđer Bošković Institute, Bijenička Cesta 54, HR-10000 Zagreb, Croatia
2BCA-Research, BCA-Clinic Betriebs GmbH & Co. KG, D-86159 Augsburg, Germany
3Institute of Cancer Therapeutics, Faculty of Life Sciences, University of Bradford, Bradford BD7 1DP, UK
4Physics of Synthetic Biological Systems-E14, Physics Department and ZNN, Technische Universität München, D-85748 Garching, Germany
5Faculty of Electrical Engineering and Computing, University of Zagreb, Unska 3, HR-10000 Zagreb, Croatia
6School of Medicine, Catholic University of Croatia, Ilica 242, HR-10000 Zagreb, Croatia
7Faculty of Pharmacy and Biochemistry, University of Zagreb, A. Kovačića 1, HR-10000 Zagreb, Croatia
8Comlamed, Friedrich-Bergius Ring 15, D-97076 Würzburg, Germany
*Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2023, 24(6), 5594; https://doi.org/10.3390/ijms24065594
Received: 18 February 2023 / Revised: 7 March 2023 / Accepted: 11 March 2023 / Published: 15 March 2023
(This article belongs to the Special Issue Transcriptomics in Health and Disease)

Abstract

Borreliella (syn. Borrelia) burgdorferi is a spirochete bacterium that causes tick-borne Lyme disease. Along its lifecycle B. burgdorferi develops several pleomorphic forms with unclear biological and medical relevance. Surprisingly, these morphotypes have never been compared at the global transcriptome level. To fill this void, we grew B. burgdorferi spirochete, round body, bleb, and biofilm-dominated cultures and recovered their transcriptomes by RNAseq profiling. We found that round bodies share similar expression profiles with spirochetes, despite their morphological differences. This sharply contrasts to blebs and biofilms that showed unique transcriptomes, profoundly distinct from spirochetes and round bodies. To better characterize differentially expressed genes in non-spirochete morphotypes, we performed functional, positional, and evolutionary enrichment analyses. Our results suggest that spirochete to round body transition relies on the delicate regulation of a relatively small number of highly conserved genes, which are located on the main chromosome and involved in translation. In contrast, spirochete to bleb or biofilm transition includes substantial reshaping of transcription profiles towards plasmids-residing and evolutionary young genes, which originated in the ancestor of Borreliaceae. Despite their abundance the function of these Borreliaceae-specific genes is largely unknown. However, many known Lyme disease virulence genes implicated in immune evasion and tissue adhesion originated in this evolutionary period. Taken together, these regularities point to the possibility that bleb and biofilm morphotypes might be important in the dissemination and persistence of B. burgdorferi inside the mammalian host. On the other hand, they prioritize the large pool of unstudied Borreliaceae-specific genes for functional characterization because this subset likely contains undiscovered Lyme disease pathogenesis genes.
_______________
**Comment**
And herein lies the age-old problem: unstudied Borreliaceae-specific genes that have not been functionally characterized, and undiscovered Lyme disease pathogenesis genes.  Everything else hinges on these unknowns.
This research is begging to be done, but has been avoided like the plague because of corrupt public health, run by one man doling out research grants whom has far too much power, and whom receives untracked, secret royalty payments.
COVID has shown the world what Lyme/MSIDS patients have been facing, only they have been in this hideous time-warp for over 40 years. Researchers are smart – they know they must cow-tow to the NIAID mafia overlord to get research funding, which means they must espouse the accepted narrative that Lyme is a simple nuisance cured with a couple weeks of a mono-therapy that hasn’t worked from the get-go.
Nobody seems to care but sick patients and a handful of ethical researchers who feverishly attempt to move a 40 year old needle that’s covered with an inch of rust.  When dissenting research finally does come out, it is retracted for flimsy reasons, in this case due to testing methods, but my educated guess is the research simply couldn’t stand because it revealed too much truth.  This is quite ironic considering the COVID ‘pandemic’ only occurred due to faulty testing insisted upon & patented by corrupt public health which quietly had to withdraw its EUA because it can’t distinguish between COVID and the regular flu.  Monopolizing medicine/disease is the CDC & FDA‘s MO and this includes testing, as virtually everything else spawns off of testing.  Control testing and you control the entire paradigm from research to drugs.
This diabolical monopoly then sets the ball rolling for the entire world, again demonstrating the frightening monopoly that must be broken.  Mainstream medicine, which is lazy, remains brain-washed and simply follows orders. And compliance is what corrupt public health is counting on.  Truth is crucified and dissenters are promptly tarred and feathered despite saving lives.  Censorship, bullying, firing and closing labs down, tossing out and manipulating data, fake science, and “disappearing” are efficiently deployed to silence any opposition.
Believe it or not, mainstream medicine still does not even believe Bb is pleomorphic.

Published Writings Exposing the CDC’s False Lyme Disease Narrative

https://www.change.org/p/the-us-senate-calling-for-a-congressional-investigation-of-the-cdc-idsa-and-aldf/

Published writings exposing the CDC’s false Lyme disease narrative

Carl Tuttle

Hudson, NH, United States

MAR 17, 2023 — 

Additional information sent to Mathematica Policy Research. It should be noted that there hasn’t been a single response from anyone at Mathematica or the CDC. 

Truth does not mind being questioned. A lie does not like being challenged!

———- Original Message ———-
From: CARL TUTTLE <runagain@comcast.net>
To: “achen@mathematica-mpr.com” <achen@mathematica-mpr.com>, “info@mathematica-mpr.com” <info@mathematica-mpr.com>, “pdecker@mathematica-mpr.com” <pdecker@mathematica-mpr.com>
Cc: “lwx1@cdc.gov” <lwx1@cdc.gov>, “frederick.chen@ama-assn.org” <frederick.chen@ama-assn.org>, “gmarx@cdc.gov” <gmarx@cdc.gov>, “acoyne@mathematica-mpr.com” <acoyne@mathematica-mpr.com>, “jconstantine@mathematica-mpr.com” <jconstantine@mathematica-mpr.com>, “ctrenholm@mathematica-mpr.com” <ctrenholm@mathematica-mpr.com>, “tbarnes@mathematica-mpr.com” <tbarnes@mathematica-mpr.com>, “sboudreau@mathematica-mpr.com” <sboudreau@mathematica-mpr.com>, “jdevallance@mathematica-mpr.com” <jdevallance@mathematica-mpr.com>, “sara.berg@ama-assn.org” <sara.berg@ama-assn.org>, “jack.resneck@ucsf.edu” <jack.resneck@ucsf.edu>, “jack.resneck@ama-assn.org” <jack.resneck@ama-assn.org>, “todd.unger@ama-assn.org” <todd.unger@ama-assn.org>, “jon.burkhart@ama-assn.org” <jon.burkhart@ama-assn.org>, “karen.kmetik@ama-assn.org” <karen.kmetik@ama-assn.org>, “sanjay.desai@ama-assn.org” <sanjay.desai@ama-assn.org>, “william_henderson@paul.senate.gov” <william_henderson@paul.senate.gov>
Date: 03/17/2023 11:48 AM
Subject: Published writings exposing the CDC’s false Lyme disease narrative; “Hard to catch and easily treated”

Mathematica
Princeton, NJ
Attn: Arnold Chen, Senior Researcher

Dear Dr. Chen,

Now that we know that the Covid lab leak theory being a “conspiracy theory” was a lie and the “15 days to stop the spread” was a lie and “masks work” to stop the spread was a lie and “vaccine mandates will stop the spread” was a lie and “natural immunity is a myth” was a lie and the “there is no side effects” was a lie and the “safe and 100% effective” was a lie then you can pretty much bet that “chronic Lyme does not exist” is a lie. Post Treatment Lyme Disease Syndrome is simply a fabricated medical condition disguising treatment failure because a chronic relapsing  seronegative disease does not fit the business model of vaccine development, patent royalties and pharmaceutical profits. All this suffering for the sake of a vaccine. Just like the current mismanagement of Covid … all for the sake of a vaccine. It should be blatantly obvious to everyone; pharmaceutical profits over lifesaving care. Suppressing evidence of persistent infection after antibiotic treatment for Lyme disease is criminal.

Patient testimony across America is describing a disease that is destroying lives, ending careers while leaving its victims in financial ruin.

The false Lyme disease narrative “Hard to catch and easily treated” propagated by the CDC for nearly three decades has been exposed in countless books; first and foremost, frontline treating physician Dr. Kenneth Liegner’s 892-page book:

In the Crucible of Chronic Lyme Disease: Collected Writings & Associated Materials 
by M.D. Kenneth B. Liegner

“In the fullness of time, the mainstream handling of chronic Lyme disease will be viewed as one of the most shameful episodes in the history of medicine because elements of academic medicine, elements of government and virtually the entire insurance industry have colluded to deny a disease.” -Kenneth B. Liegner M.D.

Cure Unknown: Inside the Lyme Epidemic (Revised Edition with New Chapter)
by Pamela Weintraub

Gone in a Heartbeat: A Physician’s Search for True Healing 
by Dr. Neil Spector

Lyme Madness: Rescuing My Son Down The Rabbit Hole of Chronic Lyme Disease.
by Lori Dennis

Bite Me: How Lyme Disease Stole My Childhood, Made Me Crazy, and Almost Killed Me
by Ally Hilfiger, Tommy Hilfiger – foreword, et al

The Opposite of Fate by Amy Tan

Suffering the Silence: Chronic Lyme Disease in an Age of Denial
by Allie Cashel, Mandy Kaplan, et al.

Believe Me: My Battle with the Invisible Disability of Lyme Disease
by Yolanda Hadid, Daisy White, et al.

When Your Child Has Lyme Disease: A Parent’s Survival Guide
by Sandra K Berenbaum, Dorothy Kupcha

But She Looks Fine: From Illness to Activism
by Olivia Goodreau

Lyme disease: Can Justin Bieber recover?
by Richard Rawls

What Lurks in the Woods: Struggle and Hope in the Midst of Chronic Illness, A Memoir
by Nicole Bell

Australian Lyme Crimes: The Global Disgrace
by Julie Mellae

Starving to Heal in Siberia: My Radical Recovery from Late-Stage Lyme Disease and How It Could Help Others
by Michelle B. Slater PhD, Carol Jacobanis, et al.

Lyme Rage: A Mother’s Struggle To Save Her Daughter from Lyme Disease
by Mindy Haber

Silent Suffering: Finding God’s Faithfulness in Chronic Lyme Disease
by Lauren Murphree and Andrew Murphree

Holding Hope: One Family’s Odyssey through Lyme Disease and Psychosis
by Marabai Rose

Out of the Woods: Healing from Lyme Disease for Body, Mind, and Spirit
by Katina Makris, Richard Horowitz, et al.

Dear Lyme Disease: Transforming Your Pain into Purpose
by Wendi M. Lindenmuth, Megan Hudgins, et al.

Shadows of Lyme Disease
by Ron Landis

Ticked Off: A Physician Shares How He Beat Lyme and Got His Life Back
by Dr Gordon Crozier

There’s a Deer at the Door and a Cow in the Mudroom: Learning to Live while Living with Lyme
by Jamie Bennett

THE GIFT OF LYME DISEASE AND CO-INFECTIONS
by Suzen Chan

Fighting for My Life: How I Found God and Beat Lyme Disease
by Patrick Collins

Tickled Imagination: A teenager’s reality living with undiagnosed Lyme Disease
by Lauren Kingsly

Not If, When: Lyme Disease in Verse
by Gail Tierney

Cancer on a Harley – Or is It? Lyme Disease
by Lisa Torbert

It’s All In My Head: A Journey of Healing & Transformation Through Chronic Lyme Disease
by Joe Cusamano

A Twist of Lyme: Battling a Disease That “Doesn’T Exist”
by Andrea H. Caesar

Over My Dead Body: What I Learned During My Decade-long Journey to Heal from Lyme Disease and Coinfections
by Mary Lyn Hammer

In Limbo Over Lyme Disease
by Melanie S. Weiss

Summary:

We are dealing with a life-altering/life-threatening infection with faulty/misleading antibody tests, inadequate treatment, misguided medical training and absolutely no disease control whatsoever; a public health disaster.

Has Mathematica Policy Research been pulled into this crime against humanity while being paid by the CDC to propagate the well-established false Lyme disease narrative under the guise of “GUIDANCE”?

A response to this inquiry is requested.

Carl Tuttle
Hudson, NH

When Treating Bartonella Clears Symptoms of Autism, What Next?

https://www.lymedisease.org/when-treating-bartonella-clears-autism/

When treating Bartonella clears symptoms of autism, what next?

By Debbie Kimberg

March 14, 2023

My 16-year-old autistic son’s learning disabilities suddenly resolved after treatment for congenital Bartonella and Lyme infections. (See: After 80% improvement in autism symptoms, he’s going to college.) This turn of events totally shocked our family and left us scrambling to figure out our next steps.

Before beginning treatment for Bartonella, Sammy had a tutor named Annie. This sweet, patient young woman came weekly to our home to help him organize his work and make sure he turned it in.

A few months after starting treatment, Sammy began resisting Annie’s assistance. He’d routinely exclaim, “Mom, I don’t need her help! I’m doing fine by myself!”

At first, I thought his angry behaviors were resurfacing. But then I paid closer attention to his grades and realized that he was right. My son, who had suffered with learning differences and ADHD, could suddenly do his schoolwork with no support from anyone else.

Not only did his ADHD resolve, but his grades in his core classes moved from Cs to As. What a baffling and exciting time for our family!

Learning new words

Concurrently, Sammy began asking me the meaning of all kinds of words. They were words that you would expect a 16-year-old to know, such as tremor, simmer, and immature. With Sammy’s new desire to broaden his vocabulary, we played a word game, though we never called it that.

I deliberately began to speak using larger, more advanced words, coyly embedding the meaning into the sentence to ensure he understood it. Interestingly, he was quick to try to incorporate that same word into conversation to showcase his mastery. He was a sponge! Sammy smiled proudly when he spoke, as he skillfully used a new word in a conversation.

Our vocabulary game reminded me of Forrest Gump running from the school bullies who chased him and how the braces fell off Forrest’s legs and onto the dirt road. It was as if a similar shackle on Sammy’s brain had inhibited his learning. Once it was removed, his ability to learn was remarkable.

Nurturing a new stage in learning

Before, our job as parents had involved helping him get his high school technical diploma (targeted to special education students). Now, we needed to help him catch up on all of the learning he had clearly missed due to this disease and the brain inflammation it caused. Our hope was for him to earn a full high school diploma.

This was uncharted territory.

We believed that a private school would be better equipped to handle his new, unique learning needs. But how could I even begin to explain to a school administrator what had happened, and Sammy’s unusual learning needs?

Although I thought it would be a strange conversation to have, I expected that admissions officers would be supportive and want to work with us. Instead, school after school turned us away, even ones whose mission was to support children with learning differences. Sammy’s diagnosis of autism and his previous IQ and psychological testing didn’t meet the schools’ minimum requirements.

I grew more frustrated as every school that we pursued turned us away. I was at a loss for how to help him.

Then I had an epiphany! A different and potentially better path was needed.

Changing educational gears

Since Sammy was doing well in high school, no longer requiring special education classes and wanting to attend a four-year university, we changed gears. Now, we set our sights on what he needed to learn to take his ACT and be accepted to college. We hoped to leapfrog Sammy to a new level.

This decision turned out to be a great one. A highly regarded college-testing prep school heard what had happened and were eager to help. The owner took an immediate interest in our story and moved Sammy to the top of their long wait list.

Sammy’s ACT tutor was a perfect fit – smart, fun, compassionate—and he loved singing too. Typically, a student would receive private college test prep tutoring for 2-3 months. Sammy received weekly tutoring for 10 months. With the help of this amazing school and its staff, Sammy did well enough on his ACT to gain admission to his first choice of colleges.

The future: rehabilitation from autism

I hope one day that many other families will face the same dilemma of helping their child recover from autism symptoms. With proper screening and treatment for vector-borne infections, our education system will need to redefine its services for these children.

New school programs will be required to help recovering children, a type of rehabilitation, if you will. Much like someone might need intensive occupational therapy to learn to walk again after a car accident, those recovering from autism and brain inflammation will need rehabilitation as well.

Imagine if our country could move away from Applied Behavioral Analysis therapy (ABA – designed to increase social abilities like completing tasks, communicating, and learning new skills). Currently, demand for this therapy is so high that young children must often wait years to learn basic language, coping and hygiene skills. Instead, we could enter a new era in which our children are taught to catch up in their schooling and how to refine more advanced social skills.

Therapists would need to develop new programs and be specially trained to help our recovering autistic children become the adults they were meant to be.

And of course, with proper screening and treatment prior to, or in worst case, during pregnancy, hopefully the rates of autism will see a steady decline.

I look forward to this day with great anticipation. I believe it’s not a matter of if, but a matter of when.

What’s needed

There are important steps needed to make this dream a reality:

1) CDC recognition of this important medical cause of autism symptoms,

2) development of effective diagnostic testing and an extensive, flexible set of criteria for a doctor to make a clinical diagnosis of tick-borne diseases,

3) development of effective, reliable and fast-acting treatments for tick-borne diseases.

We need to call on the CDC and government to treat autism as the public health emergency it is. We must screen the 7 million cases of autism to identify those who’ve been impacted by Bartonella and Lyme-related infections. The CDC needs to work more aggressively, beyond the genetic research, to follow the path of a potential infectious cause of symptoms. Bartonella should be at the top of the list.

And of course, infected parents and siblings would need to be screened and treated too.

I say all of this with much love and acceptance to all on the autism spectrum. To our autistic teens and adults, we accept and appreciate who you are. It is okay to acknowledge that you may be sick through no fault of your own. And it’s okay to get treated, so you feel better. It could change your life.

To find a doctor to screen your child for tick-borne diseases, see LymeDisease.org’s Physician Directory or your state’s Lyme Facebook group.

Debbie Kimberg can be contacted through her website.  You can follow her son’s wellness journey on Instagram and TikTok at @hijackedbrains.

Disclaimer: The author is not a doctor. This article is the opinion of the author and is not intended to dispense medical advice. Please seek a doctor’s advice for diagnosis and treatment.

For more:

IV Antibiotics Helpful For PTLDS

https://danielcameronmd.com/intravenous-antibiotics-helpful-for-ptlds/

INTRAVENOUS ANTIBIOTICS HELPFUL FOR PTLDS

antibiotics-ptlds

Post Treatment Lyme Disease Syndrome (PTLDS) can develop in patients even after receiving antibiotic treatment for Lyme disease. Although the exact cause of PTLDS is unknown, it could be due to a persistent infection. PTLDS is characterized by fatigue, pain and cognitive difficulties.

In their study “Efficacy and safety of antibiotic therapy for post-Lyme disease? A systematic review and network meta-analysis,” Zhang and colleagues described a meta-analysis review of four Randomized Clinical Trials (RCT) addressing Post-Treatment Lyme Disease Syndrome.¹

The four randomized controlled trials included 485 subjects who met the following inclusion criteria:

  • Randomized controlled trials
  • Patients with Post-Lyme Disease Syndrome which has persisted for at least 6 months after treatment of the initial infection and who tested positive by IgG Western blot
  • Patients aged 18 years and above
  • Number of cases providing valid data to measure outcomes
  • Studies that the control group used placebo, while the observation group took the antibiotic

Their meta-analysis showed that ceftriaxone had better results than placebo on FSS. “FSS-11 is the most widely used scale to measure the fatigue severity of the subjects,” wrote Zhang et al.

“Ceftriaxone treatment may be the best choice for antibiotic treatment of PTLD, which provides useful guidance for antibiotic treatment of PTLD in the future.”

The systemic meta-analysis concluded that intravenous ceftriaxone may be the best choice for treating Post-Treatment Lyme Disease Syndrome.

An NIH-sponsored clinical trial demonstrated that intravenous ceftriaxone therapy improved patients’ cognitive function in the short term, according to Fallon.² There were no trials addressing pain.

The authors were not able to show significant gains in the Beck Depression Inventory (BDI), Mental Health Scale and Physical Functioning Scales. Neither were they able to show significant gains with oral doxycycline.

Zhang et al. acknowledged several limitations to their study. “The number of RCTs is small; The duration and dose of treatment in these RCTs are not uniform; The follow-up time of various RCTs is different to some extent.”

Author’s Note: I have been reluctant to recognize the term PTLDS until there is a reliable test to exclude a persistent infection. This systemic meta-analysis validated my concerns that PTLDS may be the result of a persistent infection.

References:
  1. Zhang X, Jiang Y, Chen Y, et al. Efficacy and safety of antibiotic therapy for post-Lyme disease? A systematic review and network meta-analysis. BMC Infect Dis. Jan 12 2023;23(1):22. doi:10.1186/s12879-023-07989-4
  2. Fallon BA, Keilp JG, Corbera KM, et al. A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology. Mar 25 2008;70(13):992-1003. doi:10.1212/01.WNL.0000284604.61160.2d

________________

For more:

Please note that the FDA’s continued attack on supplements and medications it deems a threat could very well impact Lyme/MSIDS patients.